Article Text

Download PDFPDF

Liposomal bupivacaine versus bupivacaine hydrochloride: are we changing the outcomes?
Free
  1. Alaa Abd-Elsayed
  1. University of Wisconsin Madison School of Medicine and Public Health, Madison, WI 53705, USA
  1. Correspondence to Dr Alaa Abd-Elsayed, University of Wisconsin Madison School of Medicine and Public Health, Madison, WI 53705, USA; alaaawny{at}hotmail.com

Statistics from Altmetric.com

Abstract

Hanns-Christian et al 1 conducted a literature review with the objective of determining whether there is a difference in postoperative pain scores and opioid consumption between patients who received liposomal bupivacaine and patients who received bupivacaine hydrochloride.

The authors concluded that the beneficial effect on both postoperative pain scores and opioid consumption was small but not clinically relevant.1

Reference

Footnotes

  • Contributors AA-E designed and produced the infographic.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles